StockData
Elevance Health, Inc. logo

Elevance Health, Inc. (ELV) stock

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3011% below fair value
$433.93−12.35 (-2.77%)

Close on Nov 17, 2026Market cap $93.75BP/E 18.5Yield –

Elevance Health operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Elevance Health's operating cash flow for the twelve months ending Sep 30, 2026 was $7.60B, up 54.6% year over year. For fiscal 2025 it was $4.29B, down 26.1% from the year before. Over ten years it grew 0.2% a year on average. The highest annual figure on record is $10.69B in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.29B-26.1%
FY2024Dec 31, 2024$5.81B-27.9%
FY2023Dec 31, 2023$8.06B-4.0%
FY2022Dec 31, 2022$8.40B+0.4%
FY2021Dec 31, 2021$8.36B-21.7%
FY2020Dec 31, 2020$10.69B+76.3%
FY2019Dec 31, 2019$6.06B+58.4%
FY2018Dec 31, 2018$3.83B-8.6%
FY2017Dec 31, 2017$4.19B+28.0%
FY2016Dec 31, 2016$3.27B-22.4%
FY2015Dec 31, 2015$4.21B+25.0%
FY2014Dec 31, 2014$3.37B+10.4%
FY2013Dec 31, 2013$3.05B+11.2%
FY2012Dec 31, 2012$2.74B-18.7%
FY2011Dec 31, 2011$3.37B+138.2%
FY2010Dec 31, 2010$1.42B-53.4%
FY2009Dec 31, 2009$3.04B+19.9%
FY2008Dec 31, 2008$2.54B-41.6%
FY2007Dec 31, 2007$4.34B–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.27B+11.6%
Q2 FY2026Jun 30, 2026$1.91B-6.9%
Q1 FY2026Mar 31, 2026$4.33B+326.0%
Q4 FY2025Dec 31, 2025$84.00M-88.1%
Q3 FY2025Sep 30, 2025$1.14B-57.6%
Q2 FY2025Jun 30, 2025$2.05B+359.5%
Q1 FY2025Mar 31, 2025$1.02B-48.6%
Q4 FY2024Dec 31, 2024$706.00M–
Q3 FY2024Sep 30, 2024$2.68B+2.4%
Q2 FY2024Jun 30, 2024$447.00M-77.1%
Q1 FY2024Mar 31, 2024$1.98B-69.4%
Q4 FY2023Dec 31, 2023-$2.97B–
Q3 FY2023Sep 30, 2023$2.61B-46.9%
Q2 FY2023Jun 30, 2023$1.95B-20.5%
Q1 FY2023Mar 31, 2023$6.47B+154.6%
Q4 FY2022Dec 31, 2022-$1.52B-190.8%
Q3 FY2022Sep 30, 2022$4.92B+96.6%
Q2 FY2022Jun 30, 2022$2.45B+45.7%
Q1 FY2022Mar 31, 2022$2.54B+1.4%
Q4 FY2021Dec 31, 2021$1.67B-56.2%
Q3 FY2021Sep 30, 2021$2.50B–
Q2 FY2021Jun 30, 2021$1.68B-69.5%
Q1 FY2021Mar 31, 2021$2.51B-0.4%
Q4 FY2020Dec 31, 2020$3.81B+187.3%
Q3 FY2020Sep 30, 2020-$1.15B-169.0%
Q2 FY2020Jun 30, 2020$5.51B+283.4%
Q1 FY2020Mar 31, 2020$2.52B+54.3%
Q4 FY2019Dec 31, 2019$1.33B+186.6%
Q3 FY2019Sep 30, 2019$1.67B+174.6%
Q2 FY2019Jun 30, 2019$1.44B+165.1%
Q1 FY2019Mar 31, 2019$1.63B-26.4%
Q4 FY2018Dec 31, 2018$463.00M–
Q3 FY2018Sep 30, 2018$607.00M-74.8%
Q2 FY2018Jun 30, 2018$542.00M+37.9%
Q1 FY2018Mar 31, 2018$2.22B-17.6%
Q4 FY2017Dec 31, 2017-$1.30B-570.4%
Q3 FY2017Sep 30, 2017$2.40B–
Q2 FY2017Jun 30, 2017$393.10M–
Q1 FY2017Mar 31, 2017$2.69B–
Q4 FY2016Dec 31, 2016$276.60M–

More Elevance Health figures

See a number that looks wrong?